Navigation Links
Thermo Fisher Scientific Unveils New Laboratory Technologies at Analytica 2008

New Technologies and Expanded Reach Across Europe Help Customers to Move

Science Forward

MUNICH, Germany, March 31 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today launched a number of innovative new products at Analytica 2008, the world's largest laboratory technology tradeshow, taking place in Munich, Germany, from April 1 - 4. The company's new technologies are focused on enabling customers to take advantage of the most advanced solutions available for their application -- from complex research to routine analysis.

"Today, we are unveiling in Europe novel tools that are built upon decades of experience in working with our customers to move science forward," said Marc N. Casper, executive vice president of Thermo Fisher Scientific. "We're excited to showcase breakthroughs covering a range of technology platforms, from RNA-interference to elemental analysis, molecular spectroscopy and mass spectrometry. You will also see how our technologies fit together to form a complete workflow, with a comprehensive protein research laboratory replicated in our booth.

"Furthermore, we continue to make strategic acquisitions that complement our technology breadth and strengthen our geographic market position. For example, our additions of NanoDrop micro UV-Vis systems, as well as Flux and La-Pha-Pack chromatography products and consumables, will allow us to more effectively deliver our unmatched offerings to customers in Europe and around the world."

The industry-leading portfolio of laboratory offerings from the company's premier brands, Thermo Scientific and Fisher Scientific, is on display in booths 105/204 and 121/220 in Hall B1. Among the new technologies, products and capabilities introduced this year are:

Elemental Analysis

Thermo Scientific iCE 3000 Series of Atomic Absorption (AA)

spectrometers -- comprising the new iCE 3300, iCE 3400 and iCE 3500, the

innovative iCE 3000 Series has been designed to facilitate prolonged and

simplified operation -- even using the most difficult samples -- with

superior functionality. These new AA spectrometers are the most compact

available and have been developed to accommodate both flame and furnace

analyses. The new Thermo Scientific AA instruments primarily address the

analytical needs of users working in the food safety industry, as well

as the environmental, clinical, pharmaceutical, metals and materials


Molecular Spectroscopy

Thermo Scientific Nicolet(TM) iS(TM)10 FT-IR spectrometer -- powered by

new OMNIC(TM) Specta(TM) software, this easy-to-use system simplifies

advanced spectroscopy, enabling chemists in analytical and investigative

chemistry laboratories to take advantage of the power of FT-IR.

Thermo Scientific Nicolet(TM) iN(TM)10 FT-IR microscope -- powered by

new OMNIC(TM) Picta(TM) software, this FT-IR microscope is a significant

development that simplifies infrared microscopy for chemists in

analytical and investigative chemistry laboratories. The enhanced iN10

MX version provides new levels of imaging performance to microscopy and

chemical imaging, without the need for an external FT-IR spectrometer.

Thermo Scientific DXR SmartRaman spectrometer -- a new Raman platform

designed specifically for the needs and environment of the quality

control (QC) laboratory, it will enable many QC labs to harness the

power of the Raman technique for the first time.

Thermo Scientific DXR Raman microscope -- designed to help non-

specialist users perform rapid sampling and analysis of small features,

down to one-micron spatial resolution, this novel microscope also offers

superior overall performance and outstanding reproducibility in a

package that anyone can use.

UV-Vis Spectroscopy

Thermo Scientific NanoDrop line of micro-volume spectroscopy systems --

these unique instruments use a patented technology that enables easy

measurement of UV-Vis and fluorescence by eliminating the use of

cuvettes and associated dilutions. The systems are designed for

applications involving small sample volumes, increasingly required in

emerging life sciences research that involves measurement of DNA and


Mass Spectrometry

Thermo Scientific LTQ Orbitrap(R) XL(TM) ETD and Thermo Scientific MALDI

LTQ Orbitrap -- these advancements bring electron transfer dissociation

(ETD) and matrix-assisted laser desorption/ionization (MALDI)

capabilities to the award-winning LTQ Orbitrap hybrid series of mass

spectrometers. The LTQ Orbitrap XL ETD is the only ETD instrument with

both high resolution and accurate mass, enabling the ultimate in

definitive protein characterization. The new MALDI LTQ Orbitrap series

accelerates the analysis of whole tissue, biological and polymer samples

by leveraging the ultrahigh resolution and accurate mass Orbitrap


RNAi Technology

Thermo Scientific Dharmacon Accell(TM) siRNA -- RNA-interference (RNAi)

is a powerful technology used to silence, or knock down, target genes

and the proteins they produce, revealing their role in biological

pathways and disease processes. Accell is a breakthrough gene-silencing

tool that greatly simplifies RNAi technology and eliminates barriers

associated with previous cellular delivery methods. The technology is

expected to accelerate research and drug discovery in many important

life sciences fields, including neuroscience, immunology, stem-cell

science and oncology.

Liquid Handling and Consumables

Thermo Scientific Finnpipette F1 and F2 Series -- the result of more

than 40 years of pipetting expertise, the new Finnpipette F-Series

includes variable and fixed volume single-channel models covering 0.2

microliters to 10 ml for assured versatility. Furthermore, multi-channel

models are available and include 8-, 12- and 16-channel pipettes

covering 1-300 microliters for even greater flexibility. The new F-

Series offers superior accuracy and the highest levels of pipetting

precision for both routine use and for quality-conscious research and

pharma-biotechnology laboratories.


Darwin LIMS(TM) 3.0 laboratory information management system -- brings

significant functionality enhancements to the pharmaceutical industry

through a purpose-built LIMS designed specifically for QA/QC, offering

environmental monitoring, dissolution, stability management, product and

batch management and system interfacing.

For full press releases announcing all new products at Analytica 2008, please visit the online media room at

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual revenues of $10 billion, we have more than 30,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit

The following constitutes a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward- looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company's Annual Report on Form 10-K for the year ended December 31, 2007, under the caption "Risk Factors," which is on file with the Securities and Exchange Commission (SEC) and available in the "Investors" section of our Website under the heading "SEC Filings." We also may make forward-looking statements about the benefits of the merger of Thermo Electron and Fisher Scientific, including statements about future financial and operating results, the new company's plans, objectives, expectations and intentions and other statements that are not historical facts. Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the risk that the businesses will not be integrated successfully; the risk that the cost savings and any other synergies from the transaction may not be fully realized or may take longer to realize than expected; disruption from the transaction making it more difficult to maintain relationships with customers, employees or suppliers; competition and its effect on pricing, spending, third-party relationships and revenues; the need to develop new products and adapt to significant technological change; implementation of strategies for improving internal growth; use and protection of intellectual property; dependence on customers' capital spending policies and government funding policies; realization of potential future savings from new productivity initiatives; general worldwide economic conditions and related uncertainties; the effect of changes in governmental regulations; the effect of exchange rate fluctuations on international operations; the effect of laws and regulations governing government contracts; the effect of competing with certain of our customers and suppliers; and the effect of rapid changes in the healthcare industry. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.

Media Contact Information:

Lori Gorski

Phone: 781-622-1242



Investor Contact Information:

Ken Apicerno

Phone: 781-622-1111


SOURCE Thermo Fisher Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
2. Thermo Fisher Scientific to Present at Investor Conferences
3. Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
4. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
5. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
6. Thermo Fisher Scientific to Present at Upcoming Investor Conferences
7. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
8. Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services
9. Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, October 25, 2007
10. Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies
11. Thermo Fisher Scientific to Expand Manufacturing Operation for Single-Use Bioprocessing Containers
Post Your Comments:
(Date:11/26/2015)... 26, 2015 --> ... in imaging technologies, announced today that it has received a ... the Horizon 2020 European Union Framework Programme for Research and ... trial in breast cancer. , --> ... --> --> The study aims to ...
(Date:11/25/2015)... 2015 Studies reveal the differences ... and pave the way for more effective treatment for one ...   --> --> ... problems in cats, yet relatively little was understood about the ... have been conducted by researchers from the WALTHAM Centre for ...
(Date:11/25/2015)... ... 25, 2015 , ... A long-standing partnership between the Academy ... been formalized with the signing of a Memorandum of Understanding. , AMA Executive ... Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA Headquarters ...
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
Breaking Biology Technology:
(Date:11/9/2015)... ) ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition of ... 2015-2019" report to their offering. ... ) has announced the addition of the ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... , Oct. 29, 2015 Daon, a ... that it has released a new version of its ... in North America have already ... v4.0 also includes a FIDO UAF certified server ... already preparing to activate FIDO features. These customers include ...
Breaking Biology News(10 mins):